WMT

124.32

+0.74%↑

COST

996.39

+0.02%↑

TGT

121.01

+2.06%↑

KR

72.34

-1.63%↓

DG.US

118.62

+0.7%↑

WMT

124.32

+0.74%↑

COST

996.39

+0.02%↑

TGT

121.01

+2.06%↑

KR

72.34

-1.63%↓

DG.US

118.62

+0.7%↑

WMT

124.32

+0.74%↑

COST

996.39

+0.02%↑

TGT

121.01

+2.06%↑

KR

72.34

-1.63%↓

DG.US

118.62

+0.7%↑

WMT

124.32

+0.74%↑

COST

996.39

+0.02%↑

TGT

121.01

+2.06%↑

KR

72.34

-1.63%↓

DG.US

118.62

+0.7%↑

WMT

124.32

+0.74%↑

COST

996.39

+0.02%↑

TGT

121.01

+2.06%↑

KR

72.34

-1.63%↓

DG.US

118.62

+0.7%↑

Search

Universal Corp-VA

Geschlossen

BrancheKonsumgüter defensiv

52.72 -0.81

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

52.38

Max

53.22

Schlüsselkennzahlen

By Trading Economics

Einkommen

-7.4M

33M

Verkäufe

107M

861M

KGV

Branchendurchschnitt

11.921

27.787

EPS

1.32

Dividendenrendite

6.12

Gewinnspanne

3.86

Angestellte

11,400

EBITDA

13M

94M

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

6.12%

3.82%

Nächstes Ergebnis

28. Mai 2026

Nächste Dividendenausschüttung

4. Mai 2026

Nächstes Ex-Dividendendatum

15. Apr. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

56M

1.3B

Vorheriger Eröffnungskurs

53.53

Vorheriger Schlusskurs

52.72

Nachrichtenstimmung

By Acuity

67%

33%

117 / 131 Ranking in Consumer defensive

Technischer Score

By Trading Central

Vertrauen

Weak Bearish Evidence

Universal Corp-VA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

31. März 2026, 23:31 UTC

Heiße Aktien

Stocks to Watch: Nike, RH, NCino

31. März 2026, 22:35 UTC

Ergebnisse

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1. Apr. 2026, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31. März 2026, 23:50 UTC

Akquisitionen, Fusionen, Übernahmen

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31. März 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31. März 2026, 23:33 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31. März 2026, 23:21 UTC

Ergebnisse

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31. März 2026, 23:14 UTC

Market Talk
Ergebnisse

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31. März 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke 2025 Loss Widens >000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31. März 2026, 22:36 UTC

Ergebnisse

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31. März 2026, 21:46 UTC

Akquisitionen, Fusionen, Übernahmen

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31. März 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31. März 2026, 21:35 UTC

Ergebnisse

Nike Expects China Sales Down 20% in 4Q, CFO Says

31. März 2026, 21:35 UTC

Ergebnisse

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31. März 2026, 21:35 UTC

Ergebnisse

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31. März 2026, 21:33 UTC

Akquisitionen, Fusionen, Übernahmen

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31. März 2026, 21:33 UTC

Ergebnisse

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31. März 2026, 21:32 UTC

Ergebnisse

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31. März 2026, 21:28 UTC

Ergebnisse

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31. März 2026, 21:26 UTC

Ergebnisse

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31. März 2026, 21:25 UTC

Ergebnisse

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31. März 2026, 21:24 UTC

Market Talk
Ergebnisse

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31. März 2026, 21:22 UTC

Ergebnisse

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31. März 2026, 21:22 UTC

Ergebnisse

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31. März 2026, 21:21 UTC

Ergebnisse

Nike's Digital Channel Still Too Promotional, CFO Says

31. März 2026, 21:20 UTC

Ergebnisse

Nike CEO: Converse Remains Important to Portfolio

Peer-Vergleich

Kursveränderung

Universal Corp-VA Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

58.2 / 58.76Unterstützung & Widerstand

Kurzfristig

Weak Bearish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Bullish Evidence

Stimmung

By Acuity

117 / 131 Ranking in Konsumgüter defensiv

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Universal Corp-VA

Universal Corporation engages in sourcing, processing, and supplying leaf tobacco and plant-based ingredients worldwide. It operates through two segments, Tobacco Operations, and Ingredients Operations. The Tobacco Operations segment is involved in procuring, processing, packing, storing, and shipping of flue-cured, burley, dark air-cured, and oriental leaf tobacco for manufacturers of consumer tobacco products, as well as provision of related services; providing specialty services, such as custom blending, chemical and physical testing of tobacco, service cutting, reconstituted leaf tobacco manufacturing, and just-in-time product delivery services; and liquid nicotine for tobacco products manufacturers, as well as recycled waste materials from tobacco production. The Ingredients Operations segment engages in the production of specialty plant-based ingredients, including fruits, vegetables, herbs, fruit and vegetable juices, concentrates, pomaces, ciders, purees, nutraceuticals, fruit fibers, seeds, seed powders, dehydrated products, botanical extracts, distillates, natural flavors, colors, and other value-added products for consumer-packaged goods manufacturers and retailers, as well as food, beverage, and flavor companies. The company was founded in 1886 and is headquartered in Richmond, Virginia.
help-icon Live chat